Reviewing Amarin (NASDAQ:AMRN) & China Dongsheng International (OTCMKTS:CDSG)

China Dongsheng International (OTCMKTS:CDSG) and Amarin (NASDAQ:AMRN) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, risk and profitability.

Insider & Institutional Ownership

22.3% of Amarin shares are owned by institutional investors. 73.5% of China Dongsheng International shares are owned by insiders. Comparatively, 2.0% of Amarin shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Risk and Volatility

China Dongsheng International has a beta of 15.25, indicating that its stock price is 1,425% more volatile than the S&P 500. Comparatively, Amarin has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for China Dongsheng International and Amarin, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
China Dongsheng International	0	0	0	0	N/A
Amarin	1	1	1	0	2.00

Amarin has a consensus target price of $1.00, indicating a potential upside of 65.51%. Given Amarin’s higher possible upside, analysts clearly believe Amarin is more favorable than China Dongsheng International.

Profitability

This table compares China Dongsheng International and Amarin’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
China Dongsheng International	N/A	N/A	N/A
Amarin	-12.66%	-6.09%	-4.11%

Valuation and Earnings

This table compares China Dongsheng International and Amarin”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
China Dongsheng International	N/A	N/A	-$100,000.00	N/A	N/A
Amarin	$264.78 million	0.94	-$59.11 million	($0.12)	-5.04

China Dongsheng International has higher earnings, but lower revenue than Amarin.

Summary

China Dongsheng International beats Amarin on 6 of the 10 factors compared between the two stocks.

About China Dongsheng International

China Dongsheng International, Inc. engages in the acquisition, exploration, and development of mineral properties. The company primarily explores for lithium. It holds an 80% interest in the Titan Projects located in Tanzania; and has right to earn 60% interest in the West End Lithium Project near Tonopah Nevada. China Dongsheng International, Inc. is based in Las Vegas, Nevada.

About Amarin

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.